Attenuation of stunning by the calcium antagonist nisoldipine in patients with myocardial infarction and early percutaneous transluminal coronary angioplasty

Cardiovasc Drugs Ther. 1997 Mar;11(1):19-20. doi: 10.1023/a:1007783319850.

Author

G Heusch¹

Affiliation

¹ Department of Pathophysiology, University of Essen Medical School, Germany.

PMID: 9140672
DOI: 10.1023/a:1007783319850

No abstract available

Publication types

Comment

MeSH terms

Angioplasty, Balloon* / adverse effects
Calcium Channel Blockers / therapeutic use*
Humans
Myocardial Infarction / complications
Myocardial Infarction / physiopathology
Myocardial Infarction / therapy*
Myocardial Reperfusion Injury / drug therapy*
Myocardial Reperfusion Injury / etiology
Myocardial Reperfusion Injury / physiopathology
Nisoldipine / therapeutic use*

Substances

Calcium Channel Blockers
Nisoldipine